GlassScriptPhysician profile
Nabil Ahmad
NPI 1508021791
$1,941.29
in general payments reported to CMS, 2019-2025
17 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $311 · 2023: $555 · 2024: $484 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.39 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $264.26 | 2023-2025 | Ajovy |
| Abbvie INC. | $255.64 | 2021-2023 | Qulipta, Botox, Ubrelvy |
| Biogen, INC. | $221.75 | 2021-2022 | |
| Ucb, INC. | $125.00 | 2024 | Rystiggo |
| Biohaven Pharmaceuticals, INC. | $124.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.27 | 2024 | Hyqvia |
| Mdd US Operations, LLC | $118.83 | 2024 | Gocovri |
| Tg Therapeutics, INC. | $104.16 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $102.60 | 2024 | Rexulti |
| Impel Pharmaceuticals INC. | $101.32 | 2022 | |
| Lundbeck LLC | $96.54 | 2025 | Vyepti |
| Genentech, INC. | $95.11 | 2022 | |
| Argenx US, INC. | $89.37 | 2023 | Vyvgart |
| Boston Scientific Corporation | $50.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.48 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.21 | 2021 | |
| Eisai INC. | $18.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.